Document is current
Any future updates will be listed below
-
Authors
Tjader, Nijole Pollock
Ramroop, Johnny
Gandhi, Tanish
Dauch, Cara
Meadows, Owen
Stevens, Patrick
Pearlman, Rachel
Hampel, Heather
Aglago, Elom K.
Berndt, Sonja I.
Bloomer, Amanda
Brenner, Hermann
Buchanan, Daniel D.
Campbell, Peter T.
Cao, Yin
Chan, Andrew T.
Cheng, Iona
Dimou, Niki
Drew, David A.
French, Amy J.
Georgeson, Peter
Giannakis, Marios
Giles, Graham G.
Gomez, Maria
Gruber, Stephen B.
Hoffmeister, Michael
Huang, Wen-Yi
Hullar, Meredith A. J.
Huyghe, Jeroen R.
Loroña, Nicole
Moreno, Victor
Newton, Christina C.
Nowak, Jonathan A.
Obón-Santacana, Mireia
Ogino, Shuji
Pellatt, Andrew
Peoples, Anita R.
Permuth, Jennifer B.
Schmit, Stephanie L.
Schoen, Robert E.
Siegel, Erin M.
Steinfelder, Robert S.
Sun, Wei
Teer, Jamie K.
Thomas, Claire E.
Trinh, Quang M.
Tsilidis, Konstantinos
Ugai, Tomotaka
Um, Caroline Y.
Van Guelpen, Bethany
Zaidi, Syed H.
Figueiredo, Jane
Peters, Ulrike
Phipps, Amanda I.
McElroy, Joseph Paul
Toland, Amanda Ewart
-
Funding
Funding for this research was provided by:
Pelotonia (Pelotonia Graduate Research Fellowship)
Pelotonia (Pelotonia Postdoctoral Fellowship)
Pelotonia (Undergraduate Research Fellowship)
National Institutes of Health (R01 CA81488)
National Institutes of Health (R01 CA248857)
National Institutes of Health (R50 CA274122)
National Institutes of Health (R01 CA155101)
American Cancer Society (CRP-24-1185864-01-PROF)
Prevent Cancer Foundation
Brigham and Women’s Hospital (Faculty Career Development Award)
American Institute for Cancer Research (Investigator Initiated Grant)
Harvey V. Fineberg Cancer Prevention Fellowship
National Cancer Institute (R01 CA215151)
- License Information
-
More Information
Article History
Received: 18 June 2025
Accepted: 6 February 2026
First Online: 13 February 2026
Declarations
:
: Heather Hampel consults for LynSight, Exact Sciences, Genome Medical, GI OnDemand, and Carelon, and holds stock/stock options for Genome Medical and GI OnDemand. Jonathan Nowak receives research support from Natera and is a consultant for Leica Biosystems. Shuji Ogino served as a consultant for Sanofi Pasteur S.A. Ulrike Peters was a consultant with AbbVie and her husband holds individual stocks for the following companies: Amazon, ARM Holdings PLC, BioNTech, BYD Company Limited, Crowdstrike Holdings Inc, CureVac, Google/Alphabet, Microsoft Corp, NVIDIA Corp, and Stellantis. The other authors declare no conflicts of interest.
